AR002244A1 - Nuevos derivados de [3-(4-fenilpiperacin-1-il)propilamino]-piridina y benceno como antagonistas de ó 1-andrenoceptores, una composicion farmaceuticaque los contiene, un procedimiento para su preparacion y empleo de los mismos. - Google Patents

Nuevos derivados de [3-(4-fenilpiperacin-1-il)propilamino]-piridina y benceno como antagonistas de ó 1-andrenoceptores, una composicion farmaceuticaque los contiene, un procedimiento para su preparacion y empleo de los mismos.

Info

Publication number
AR002244A1
AR002244A1 ARP950100065A AR10006595A AR002244A1 AR 002244 A1 AR002244 A1 AR 002244A1 AR P950100065 A ARP950100065 A AR P950100065A AR 10006595 A AR10006595 A AR 10006595A AR 002244 A1 AR002244 A1 AR 002244A1
Authority
AR
Argentina
Prior art keywords
alkyl
alkyloxy
halo
heteroaryl
cyano
Prior art date
Application number
ARP950100065A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR002244A1 publication Critical patent/AR002244A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Nuevos derivados de [3-(4-fenilpiperacin-1-il)propilamino]-piridina y benceno como antagonistas de Ó1-andrenoceptores, una composición farmacéuticaque los contienen, un procedimiento para su preparación y empleo de los mismos de fórmula (I), en donde P es 0 ó 1; t es 0, 1 ó 2; X es O, S ó NR6 (en dondeR6 es hidro o (C1-6) alquilo; Y y Z son independientemente CH o N; R1 es hidro, hidroxilo, halo, nitro, amino, ciano, (C2-4)-alquiltio, acetilamino,trifluoracetilamino, metilsulfonilamino, C(1-6)alquilo, (C3-6)cicloalquilo, (C3-6)-cicloalquil-(C1-4)alquilo, oxazol-2-ilo, arilo, heteroarilo, aril-(C1-4)-alquilo, heteroaril(C1-4)alquilo, (C2-6)alquiloxilo, (C3-6)ciclo-alquil-oxilo, (C3-6)cicloalquil(C1-4)alquiloxilo, 2-propiniloxilo,ariloxilo,heteroariloxilo,aril(C2-4)alquiloxilo o heteroaril(C1-4)alquiloxilo (en donde alquilo está opcionalmente sustituido por uno a tres átomos de halo y arilo o heteroariloestá opcionalmente sustituido por uno o dos sustituyentes elegidos independientemente entre halo y ciano; R2 es hidro, hidroxilo, halo, ciano,(C2-6)alquilo o (C2-6)-alquiloxilo (en donde alquilo está opcionalmente sustituido por uno a tres átomos de halo);R3 es -C(O)R7, (en donde R7 es(C1-6)alquilo, (C3-6)cicloalquilo, di(C1-4)alquilamino, N-(C1-4)alquil-N-(C1-4) alquiloxiamino, (C1-4)alquil(C1-4)alquiloxiamino,pirrolidin-1-ilo, piperidin-1-ilo, morfolin-4-ilo o piperacin-1-ilo; R4 es halo, hidroxilo, ciano, (C1-6) alquilo o (C1-6)alquiloxilo;y R5 es (C1-6)alquilo;y las sales farmacéuticamenteaceptables y sus N-óxidos. Estos compuestos se utilizan en el tratamiento de una enfermedad que implica directa o indirectamente una obstrucción del tractourinario inferior causado porhiperplasia prostática benigna, o se utilizan para la preparación de medicamentos para el tratamiento de una enfermedad que
ARP950100065A 1994-11-08 1995-11-06 Nuevos derivados de [3-(4-fenilpiperacin-1-il)propilamino]-piridina y benceno como antagonistas de ó 1-andrenoceptores, una composicion farmaceuticaque los contiene, un procedimiento para su preparacion y empleo de los mismos. AR002244A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/336,368 US5688795A (en) 1994-11-08 1994-11-08 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists

Publications (1)

Publication Number Publication Date
AR002244A1 true AR002244A1 (es) 1998-03-11

Family

ID=23315765

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP950100065A AR002244A1 (es) 1994-11-08 1995-11-06 Nuevos derivados de [3-(4-fenilpiperacin-1-il)propilamino]-piridina y benceno como antagonistas de ó 1-andrenoceptores, una composicion farmaceuticaque los contiene, un procedimiento para su preparacion y empleo de los mismos.

Country Status (22)

Country Link
US (1) US5688795A (es)
EP (1) EP0711757A1 (es)
JP (1) JPH08208614A (es)
KR (1) KR960017658A (es)
CN (1) CN1136039A (es)
AR (1) AR002244A1 (es)
AU (1) AU3459995A (es)
BR (1) BR9505107A (es)
CA (1) CA2162089A1 (es)
CO (1) CO4520230A1 (es)
CZ (1) CZ291095A3 (es)
FI (1) FI955376A (es)
HU (1) HUT73843A (es)
IL (1) IL115844A0 (es)
MA (1) MA23717A1 (es)
NO (1) NO954453L (es)
NZ (1) NZ280396A (es)
PE (1) PE10997A1 (es)
PL (1) PL311261A1 (es)
SG (1) SG70950A1 (es)
TR (1) TR199501387A2 (es)
ZA (1) ZA959268B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425143A1 (de) 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
CZ298217B6 (cs) * 1997-05-12 2007-07-25 Ortho-Mcneil Pharmaceutical, Inc. Arylsubstituovaný piperazin, meziprodukt pro jehoprípravu a farmaceutický prostredek s jeho obsahem
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
IT1293807B1 (it) * 1997-08-01 1999-03-10 Recordati Chem Pharm Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico
US6399614B1 (en) 1997-08-01 2002-06-04 Recordati S.A. Chemical And Pharmaceutical Company 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring
US20020193383A1 (en) * 1997-08-01 2002-12-19 Recordati S.A., Chemical And Pharmaceutical Comoany 1-(N-phenylalkylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring
US6271234B1 (en) 1997-08-01 2001-08-07 Recordati S.A., Chemical And Pharmaceutical Company 1,4-disubstituted piperazines
IT1293804B1 (it) * 1997-08-01 1999-03-10 Recordati Chem Pharm Diarilalchilpiperazine attive sulle basse vie urinarie
ZA991315B (en) * 1998-02-20 2000-11-20 Ortho Mcneil Pharm Inc Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia.
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
JP4533534B2 (ja) 1998-06-19 2010-09-01 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド グリコーゲンシンターゼキナーゼ３のインヒビター
US6465467B1 (en) 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
US6355801B1 (en) * 1999-11-08 2002-03-12 Schering Corporation Process for preparing N-(4-hydroxyphenyl)-N′-(4′-aminophenyl)-piperazine
CA2449899C (en) 2000-11-20 2010-04-06 Biovitrum Ab Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
JP2004514711A (ja) 2000-11-30 2004-05-20 ランバクシー　ラボラトリーズ　リミテッド 尿選択的アルファ１アドレナリン受容体遮断薬として有用な１，４−２基置換ピペラジン誘導体
CA2485537A1 (en) 2002-06-19 2003-12-31 Biovitrum Ab Novel compounds, their use and preparation
UA89035C2 (ru) 2003-12-03 2009-12-25 Лео Фарма А/С Эфиры гидроксамовых кислот и их фармацевтическое применение
MY140489A (en) * 2003-12-26 2009-12-31 Eisai R&D Man Co Ltd 1,2-di (cyclic) substituted benzene compounds
US20070219213A1 (en) * 2004-05-20 2007-09-20 Soares Romeiro Luiz A Use of Adrenergic N-Phenylpiperazine Antagonists, Pahrmaceutical Compositions Containning Them, and Methods of Preparing Them
EP2077262A4 (en) * 2006-10-23 2011-12-28 Takeda Pharmaceutical IMINOPYRIDINE DERIVATIVES AND THEIR USE
WO2009051112A1 (ja) * 2007-10-15 2009-04-23 Takeda Pharmaceutical Company Limited アミド化合物およびその用途
US20110039892A1 (en) * 2008-04-23 2011-02-17 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
NZ588909A (en) * 2008-04-23 2012-08-31 Takeda Pharmaceutical Iminopyridine derivatives and use thereof
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
CN101585781B (zh) * 2009-07-08 2012-08-08 北京颖新泰康国际贸易有限公司 一种邻氨基-n,n-二甲基苯甲酰胺的制备方法
CN103387531A (zh) * 2012-05-10 2013-11-13 广州医学院 酰胺类芳基哌嗪衍生物及其制备方法和在抗良性前列腺增生中的应用
CN114163383A (zh) * 2021-12-24 2022-03-11 江苏丰山集团股份有限公司 一种烟嘧磺隆中间体烟酰胺和磺酰胺的绿色生产工艺
CN115611802B (zh) * 2022-12-02 2023-03-14 北京迪泰医药科技有限公司 一种3-乙酰基-2-氯吡啶的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635976A (en) * 1967-12-20 1972-01-18 Pennwalt Corp 1 - heterocyclic alkyl-1 2 3 4-tetrahydroquinazolinones and analgesic intermediates thereof
BE787126A (fr) * 1971-08-04 1973-02-05 Byk Gulden Lomberg Chem Fab Pyrimidines substituees, procedes de preparation de ces composes et medicaments contenant lesdits composes
DE2143730A1 (de) * 1971-09-01 1973-03-08 Byk Gulden Lomberg Chem Fab Substituierte pyridine, verfahren zu deren herstellung und sie enthaltende arzneimittel
JPS49133380A (es) * 1973-04-25 1974-12-21
US4616017A (en) * 1984-06-04 1986-10-07 Merck & Co., Inc. Aminohydroxypropoxy substituted aryl compounds
GB2163150B (en) * 1984-07-19 1988-05-25 Sandoz Ltd 3-aminopropoxyaryl derivatives
FR2656609B1 (fr) * 1989-12-28 1992-03-27 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FR2678272B1 (fr) * 1991-06-27 1994-01-14 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
TR199501387A2 (tr) 1996-07-21
HUT73843A (en) 1996-09-30
PL311261A1 (en) 1996-05-13
NO954453D0 (no) 1995-11-07
CZ291095A3 (en) 1996-09-11
PE10997A1 (es) 1997-04-26
AU3459995A (en) 1996-05-16
HU9503178D0 (en) 1996-01-29
FI955376A (fi) 1996-05-09
BR9505107A (pt) 1997-09-09
US5688795A (en) 1997-11-18
ZA959268B (en) 1997-01-31
NZ280396A (en) 1997-05-26
JPH08208614A (ja) 1996-08-13
SG70950A1 (en) 2000-03-21
FI955376A0 (fi) 1995-11-08
IL115844A0 (en) 1996-01-31
CO4520230A1 (es) 1997-10-15
KR960017658A (ko) 1996-06-17
NO954453L (no) 1996-05-09
EP0711757A1 (en) 1996-05-15
MA23717A1 (fr) 1996-07-01
CA2162089A1 (en) 1996-05-09
CN1136039A (zh) 1996-11-20

Similar Documents

Publication Publication Date Title
AR002244A1 (es) Nuevos derivados de [3-(4-fenilpiperacin-1-il)propilamino]-piridina y benceno como antagonistas de ó 1-andrenoceptores, una composicion farmaceuticaque los contiene, un procedimiento para su preparacion y empleo de los mismos.
AR012593A1 (es) Pirrolopiridinas sustituidas, composicion farmaceutica que las contiene, procedimiento para su preparacion y el uso de las mismas en la manufacturade un medicamento
CO5560573A2 (es) Derivados activos de amino-ftalazinona como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que los contienen
AR033845A1 (es) Compuestos de aza y poliaza-naftalenil carboxamidas utiles como inhibidores de la integrasa del vih, composiciones y su uso en la preparacion de medicamentos
AR035305A1 (es) Derivados y analogos del acido 3-arilpropionico, proceso para su preparacion, formulaciones farmaceuticas, uso de los mismos en la elaboracion de medicamentos, y formulacion farmaceutica para usar en la profilaxis y/o tratamiento de trastornos clinicos asociados con la resistencia a la insulina
AR003428A1 (es) Derivados de pirimidindiona o triazindiona como antagonista de los receptores adrenergenicos alfa1, procedimiento para su preparacion, composicion farmaceutica que los contiene y uso de dichos compuestos para la preparacion de medicamentos.
RU95108387A (ru) Дикетопиперазин, способ его получения, фармацевтическая композиция, применение дикетопиперазина
AR035557A1 (es) Un metodo para el tratamiento de desordenes proliferativos de las celulas asociadas con una actividad alterada de la cinasa dependiente de las celulas, un derivado de 3-ureido-pirazol, un procedimiento para su preparacion y una composicion farmaceutica que comprende dicho derivado
HUP0105414A2 (hu) Pirrolo-izokinolin-, azepino- és diazepino-indol-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
UA26401C2 (uk) Заміщеhі 3-аміhохіhуклідиhи
UY26143A1 (es) Derivados heterocíclicos útiles como agentes anticancerosos
HUP0301389A2 (hu) Purinszármazékok
NO20053827L (no) Nye forbindelser.
HUP0400558A2 (hu) Helyettesített benzolszármazékok, illetve sóik és ezeket tartalmazó gyógyszerkészítmények
MX9300786A (es) Compuestos hipolipidaemicos.
AR003126A1 (es) Nuevos derivados de la camptotecina sustituidos que poseen actividad antitumoral, un procedimiento para su preparacion, y composicionesfarmaceuticas que los contienen.
ES2107212T3 (es) Derivados de 1,4-benzoxazina como abridores de los canales de potasio.
HUP0003413A2 (hu) Új kondenzált piridinszármazékok, eljárás előállításukra és az azokat tartalmazó gyógyászati készítmények
HUP0400370A2 (hu) Antibakteriális hatású oxazolidinonszármazékok, előállításukra szolgáló eljárás, azokat hatóanyagként tartalmazó gyógyászati készítmények, alkalmazásuk és intermedierek
AR007108A1 (es) Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes.
HUP0003577A2 (hu) Tetrahidro-gamma-karbolinok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
AR036074A1 (es) Derivados de aminoquinolina, las composiciones farmaceuticas que los contienen, el uso de los mismos para la preparacion de una composicion farmaceutica, un procedimiento para su preparacion y los intermediarios empleados en dicho procedimiento de preparacion
HUP0401018A2 (hu) 2H-1-benzopirán-származékok, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények
MX9405110A (es) Nuevos derivados de (1-heteroazolil-1-heterociclil)alcano y su uso comoagentes neuroprotectores.
ES2063513T3 (es) Nuevos derivados del oxazol, su preparacion y las composiciones farmaceuticas que les contienen.